Showing results (611-620 of 1,130) with videos related to
Sort By:
Pageof 113
American Journal of Clinical Pathology|February 1, 1988
White blood cell aplasia associated with thymomaS P Ackland, M E Bur, S S Adler, et al.Progress in Growth Factor Research|January 1, 1989
The solution structures of epidermal growth factor and transforming growth factor alphaI D Campbell, R M Cooke, M Baron, et al.Journal De Radiologie|July 1, 1997
[Prenatal MRI of the brain. Retrospective study apropos of 34 tests]F Lair-Milan, A Gelot, J M Baron, et al.Iscience|June 1, 2026
Global transcriptional changes across multiple isogenic C9orf72 patient iPSC-derived neuronsAparna Sreeram, Desiree M Baron, Alberto Brusati, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 1983
Randomized study of cyclophosphamide, doxorubicin, and etoposide (VP16-213) with or without cisplatinum in non-small cell lung cancerJ Z Fuks, J Aisner, D A Van Echo, et al.Orbit (Amsterdam, Netherlands)|February 27, 2014
Propranolol as first-line treatment in orbital infantile haemangiomas: a case seriesM Levitt, A D Coumou, L Groeneveld, et al.Journal of Immunology (Baltimore, Md. : 1950)|March 2, 2011
The phosphatase SRC homology region 2 domain-containing phosphatase-1 is an intrinsic central regulator of dendritic cell functionIndu R Ramachandran, Weitao Song, Natalia Lapteva, et al.Biological Psychiatry|October 1, 1984
Sodium lactate infusion, panic attacks, and ionized calciumA J Fyer, J M Gorman, M R Liebowitz, et al.Genetika|October 1, 1982
[Chinese hamster cells with mutation in the hypoxanthine-guanine phosphoribosyltransferase locus. III. The biochemical characteristics of the hypoxanthine-guanine phosphoribosyltransferase of complementing mutants]E V Moiseenko, E V Luss, L V Volkova, et al.Protein Engineering|September 1, 1992
Ligand requirements for Ca2+ binding to EGF-like domainsM Mayhew, P Handford, M Baron, et al.Pageof 113